Prognosis of recurrent non-small cell lung cancer following complete resection

Prognosis following recurrence subsequent to complete resection of non-small-cell lung cancer (NSCLC) is considered a multifactorial process dependent on clinicopathological, biological and treatment characteristics. Gefitinib was approved for lung cancer treatment in Japan in 2002. The aim of the c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: SASAKI, HIDEFUMI, SUZUKI, AYUMI, TATEMATSU, TSUTOMU, SHITARA, MASAYUKI, HIKOSAKA, YU, OKUDA, KATSUHIRO, MORIYAMA, SATORU, YANO, MOTOKI, FUJII, YOSHITAKA
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961426/
https://ncbi.nlm.nih.gov/pubmed/24944713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.1861
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares